Novartis Oncology Leadership Discuss Future of Oncology
Apr 20, 2016
While advancements in oncology research are happening faster than ever, we at Novartis are striving to remain at the forefront of innovation. We believe that precision medicine, combination therapies and immuno-oncology are beneficial areas of focus for our research that will serve to advance patient treatment.
As the world’s top leaders in oncology gather at this year’s World Medical Innovation Forum, we look forward to continuing to progress in our efforts to transform the treatment landscape and help those living with cancer battle the disease. Click here to learn more about Novartis and our commitment to advancing oncology research for patients and stories about our state-of-the-art approaches.
In a time where there are so many exciting advancements being made in cancer research, Novartis is excited to be the lead sponsor of the second annual World Medical Innovation Forum (WMIF), which is set to take place April 25-27, 2016 in Boston, MA. During the conference, some of the most creative minds in the field will gather to discuss the ever changing health care landscape and new trends that are coming to front. Alongside many experts and leaders in the oncology field, Novartis executives will participate in various panel discussions and events focusing on patient innovation and advancements in oncology research.
Join the conversation on Twitter by using #WMIF2016.